Applied Therapeutics (NASDAQ:APLT – Get Free Report) and Anika Therapeutics (NASDAQ:ANIK – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Applied Therapeutics and Anika Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Applied Therapeutics | 1 | 2 | 0 | 0 | 1.67 |
| Anika Therapeutics | 1 | 1 | 2 | 0 | 2.25 |
Applied Therapeutics currently has a consensus price target of $1.00, suggesting a potential upside of 870.87%. Anika Therapeutics has a consensus price target of $19.00, suggesting a potential upside of 43.07%. Given Applied Therapeutics’ higher probable upside, equities analysts clearly believe Applied Therapeutics is more favorable than Anika Therapeutics.
Profitability
This table compares Applied Therapeutics and Anika Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Applied Therapeutics | N/A | -340.84% | -175.00% |
| Anika Therapeutics | -1.43% | 1.87% | 1.39% |
Valuation & Earnings
This table compares Applied Therapeutics and Anika Therapeutics”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Applied Therapeutics | $1.00 million | 15.86 | -$105.62 million | ($0.10) | -1.03 |
| Anika Therapeutics | $112.82 million | 1.58 | -$10.88 million | ($0.13) | -102.15 |
Anika Therapeutics has higher revenue and earnings than Applied Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
98.3% of Applied Therapeutics shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 1.6% of Applied Therapeutics shares are held by insiders. Comparatively, 12.1% of Anika Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
Applied Therapeutics has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500.
About Applied Therapeutics
Applied Therapeutics is a biotechnology company focused on developing small-molecule medicines for rare metabolic and other serious diseases. Founded in 2016, the company is based in New York and was founded by Shoshana Shendelman, who has served as its chief executive officer. The company’s pipeline has centered on govorestat, an investigational inhibitor of the enzyme aldose reductase. Applied Therapeutics has studied the drug in conditions including classic galactosemia, SORD deficiency and PMM2-CDG, disorders that can affect multiple body systems and have limited treatment options.
About Anika Therapeutics
Anika Therapeutics is a medical technology company focused on orthopedic care and regenerative medicine. Founded in 1992 and headquartered in Bedford, Massachusetts, the company develops products using hyaluronic acid, a substance found naturally in the body and used in treatments for joint and tissue conditions. Its products include Orthovisc and Monovisc, injectable hyaluronic acid treatments for knee osteoarthritis. Anika also offers orthopedic products for areas such as sports medicine, joint preservation, and bone repair, including its Tactoset bone-void filler.
Receive News & Ratings for Applied Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
